Professor Sir Michael Owen

BSc, MB ChB, PhD, FRCPsych, FMedSci, FLSW

2016

• Rucker, J. J. et al., 2016. Phenotypic association analyses with copy number variation in recurrent depressive disorder. Biological Psychiatry 79 (4), pp.329-336. (10.1016/j.biopsych.2015.02.025)
• Tansey, K. E. et al. 2016. Common alleles contribute to schizophrenia in CNV carriers. Molecular Psychiatry 21 , pp.1085-1089. (10.1038/mp.2015.143)

2015

• Green, E. K. et al., 2015. Copy number variation in bipolar disorder. Molecular Psychiatry 21 (1), pp.89-93. (10.1038/mp.2014.174)
• Hall, J. et al. 2015. Genetic risk for schizophrenia: convergence on synaptic pathways Involved in plasticity. Biological Psychiatry 77 (1), pp.52-68. (10.1016/j.biopsych.2014.07.011)
• Heyes, S. et al., 2015. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Progress in Neurobiology 134 , pp.36-54. (10.1016/j.pneurobio.2015.09.002)
• Hosp, F. et al., 2015. Quantitative interaction proteomics of neurodegenerative disease proteins. Cell Reports 11 (7), pp.1134-46. (10.1016/j.celrep.2015.04.030)
• Huang, J. et al., 2015. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nature Communications 6 8111. (10.1038/ncomms9111)
• Jones, L. et al. 2015. Convergent genetic and expression data implicate immunity in Alzheimer's disease. Alzheimer's and Dementia 11 (6), pp.658-671. (10.1016/j.jalz.2014.05.1757)
• Kavanagh, D. et al., 2015. Schizophrenia genetics: emerging themes for a complex disorder. Molecular Psychiatry 20 (1), pp.72-76. (10.1038/mp.2014.148)
• Lancaster, T. M. et al. 2015. Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals. Alzheimer's and Dementia 11 (10), pp.1144-1152. (10.1016/j.jalz.2014.10.012)
• Lee, S. H. et al., 2015. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology 44 (5), pp.1706-1721. (10.1093/ije/dyv136)
• Maier, R. et al., 2015. Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder. American Journal of Human Genetics 96 (2), pp.283-294. (10.1016/j.ajhg.2014.12.006)
• Niarchou, M. et al. 2015. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 168 (8), pp.730-738. (10.1002/ajmg.b.32378)
• O'Dushlaine, C. et al., 2015. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nature Neuroscience 18 (2), pp.199-209. (10.1038/nn.3922)
• Oertel-Knöchel, V. et al., 2015. Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: Evidence from two independent cohorts. NeuroImage: Clinical 7 , pp.764-770. (10.1016/j.nicl.2015.03.005)
• Pocklington, A. et al. 2015. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron 86 (5), pp.1203-1214. (10.1016/j.neuron.2015.04.022)
• Rees, E. et al. 2015. Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia. Translational Psychiatry 5 (7) e607. (10.1038/tp.2015.99)
• Rees, E. , O'Donovan, M. C. and Owen, M. J. 2015. Genetics of schizophrenia. Current Opinion in Behavioral Sciences 2 , pp.8-14. (10.1016/j.cobeha.2014.07.001)
• Stergiakouli, E. et al., 2015. Shared genetic influences between attention-deficit/hyperactivity disorder (ADHD) traits in children and clinical ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 54 (4), pp.322-327. (10.1016/j.jaac.2015.01.010)
• Tansey, K. E. , Owen, M. J. and O'Donovan, M. C. 2015. Schizophrenia genetics: Building the foundations of the future. Schizophrenia Bulletin 41 (1), pp.15-19. (10.1093/schbul/sbu162)
• Walter, K. et al., 2015. The UK10K project identifies rare variants in health and disease. Nature 526 , pp.82-90. (10.1038/nature14962)

2014

• Cardno, A. G. and Owen, M. J. 2014. Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophrenia Bulletin 40 (3), pp.504-515. (10.1093/schbul/sbu016)
• Craddock, N. J. et al. 2014. Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophrenia Bulletin 40 (4), pp.729-736. (10.1093/schbul/sbu069)
• De Rubeis, S. et al., 2014. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515 , pp.209-215. (10.1038/nature13772)
• Doherty, J. and Owen, M. J. 2014. Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Medicine 6 (4) 29. (10.1186/gm546)
• Doherty, J. L. and Owen, M. J. 2014. The Research Domain Criteria: moving the goalposts to change the game. British Journal of Psychiatry 204 (3), pp.171-173. (10.1192/bjp.bp.113.133330)
• Escott-Price, V. et al. 2014. Gene-wide analysis detects two new susceptibility genes for Alzheimer's Disease. PLoS ONE 9 (6) e94661. (10.1371/journal.pone.0094661)
• Ferentinos, P. et al., 2014. Investigating the genetic variation underlying episodicity in major depressive disorder: Suggestive evidence for a bipolar contribution. Journal of Affective Disorders 155 , pp.81-89. (10.1016/j.jad.2013.10.027)
• Fromer, M. et al., 2014. De novo mutations in schizophrenia implicate synaptic networks. Nature 506 , pp.179-184. (10.1038/nature12929)
• Georgieva, L. et al. 2014. De novo CNVs in bipolar affective disorder and schizophrenia. Human Molecular Genetics 23 (24), pp.6677-6683. (10.1093/hmg/ddu379)
• Gusev, A. et al., 2014. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. American Journal of Human Genetics 95 (5), pp.535-552. (10.1016/j.ajhg.2014.10.004)
• Hung, C. et al., 2014. Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. British Journal of Psychiatry 205 (1), pp.24-28. (10.1192/bjp.bp.113.130419)
• Kaye, J. et al., 2014. Managing clinically significant findings in research: the UK10K example. European Journal of Human Genetics 22 (9), pp.1100-1104. (10.1038/ejhg.2013.290)
• Liu, G. et al., 2014. Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies. Neurobiology of Aging 35 (4), pp.786-92. (10.1016/j.neurobiolaging.2013.10.084)
• Martin, J. et al. 2014. Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: evidence from copy number variants. Journal of the American Academy of Child and Adolescent Psychiatry 53 (7), pp.761-770.e26. (10.1016/j.jaac.2014.03.004)
• Monks, S. et al., 2014. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. Schizophrenia Research 153 (1-3), pp.231-236. (10.1016/j.schres.2014.01.020)
• Mulle, J. G. et al., 2014. Reciprocal duplication of the Williams-Beuren Syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biological Psychiatry 75 (5), pp.371-7. (10.1016/j.biopsych.2013.05.040)
• Mullins, N. et al., 2014. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: A genome-wide association and polygenic scoring study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165 (5), pp.428-437. (10.1002/ajmg.b.32247)
• Niarchou, M. et al. 2014. Exploring the indirect effects of catechol-O-methyltransferase (COMT) genotype on psychotic experiences through cognitive function and anxiety disorders in a large birth cohort of children. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165 (5), pp.410-420. (10.1002/ajmg.b.32245)
• Niarchou, M. et al. 2014. Psychopathology and cognition in children with 22q11.2 deletion syndrome. British Journal of Psychiatry 204 (1), pp.46-54. (10.1192/bjp.bp.113.132324)
• Owen, M. J. 2014. New approaches to psychiatric diagnostic classification. Neuron 84 (3), pp.564-571. (10.1016/j.neuron.2014.10.028)
• Peall, K. J. et al. 2014. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. Journal of Neurology 261 (12), pp.2296-2304. (10.1007/s00415-014-7488-3)
• Pocklington, A. , O'Donovan, M. C. and Owen, M. J. 2014. The synapse in schizophrenia. European Journal of Neuroscience 39 (7), pp.1059-1067. (10.1111/ejn.12489)
• Rees, E. et al. 2014. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Human Molecular Genetics 23 (6), pp.1669-1676. (10.1093/hmg/ddt540)
• Rees, E. et al. 2014. Analysis of copy number variations at 15 schizophrenia-associated loci. British Journal of Psychiatry 204 (2), pp.108-114. (10.1192/bjp.bp.113.131052)
• Rees, E. et al. 2014. Authors' reply [Letter]. British Journal of Psychiatry 205 (1), pp.78. (10.1192/bjp.205.1.78)
• Ripke, S. et al., 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (7510), pp.421-427. (10.1038/nature13595)
• Schneider, M. et al., 2014. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: Results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. American Journal of Psychiatry 171 (6), pp.627-639. (10.1176/appi.ajp.2013.13070864)
• Steinberg, S. et al., 2014. Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry 19 (1), pp.108-114. (10.1038/mp.2012.157)
• Szatkiewicz, J. P. et al., 2014. Copy number variation in schizophrenia in Sweden. Molecular Psychiatry 19 (7), pp.762-773. (10.1038/mp.2014.40)
• Timpson, N. J. et al., 2014. A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. Nature Communications 5 4871. (10.1038/ncomms5871)

2013

• Aberg, K. A. et al., 2013. A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry 70 (6), pp.573-581. (10.1001/jamapsychiatry.2013.288)
• Barch, D. M. et al., 2013. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: Relevance to DSM-5 [Editorial Material]. Schizophrenia Research 150 (1), pp.15-20. (10.1016/j.schres.2013.04.027)
• Chapman, J. et al., 2013. A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk. Human Molecular Genetics 22 (4), pp.816-824. (10.1093/hmg/dds476)
• Chapuis, J. et al., 2013. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology [Article]. Molecular Psychiatry 18 (11), pp.1225-1234. (10.1038/mp.2013.1)
• Delio, M. et al., 2013. Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. American Journal of Human Genetics 92 (3), pp.439-447. (10.1016/j.ajhg.2013.01.018)
• Donohoe, G. et al., 2013. Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. Genes, Brain and Behavior 12 (2), pp.203-209. (10.1111/gbb.12016)
• Escott-Price, V. et al. 2013. Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk. JAMA Neurology 70 (10), pp.1268-1276. (10.1001/jamaneurol.2013.448)
• Fisher, H. L. et al., 2013. Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder. Journal of Affective Disorders 145 (1), pp.136-141. (10.1016/j.jad.2012.05.032)
• Green, E. K. et al. 2013. Association at SYNE1 in both bipolar disorder and recurrent major depression. Molecular Psychiatry 18 , pp.614-617. (10.1038/mp.2012.48)
• Green, E. K. et al. 2013. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Molecular Psychiatry 18 (12), pp.1302-1307. (10.1038/mp.2012.142)
• Grozeva, D. et al. 2013. Reduced burden of very large and rare CNVs in bipolar affective disorder. Bipolar Disorders 15 (8), pp.893-8. (10.1111/bdi.12125)
• Guha, S. et al., 2013. Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA Psychiatry 70 (3), pp.253-260. (10.1001/2013.jamapsychiatry.71)
• Hamshere, M. L. et al. 2013. High loading of polygenic risk for ADHD in children with comorbid aggression. American Journal of Psychiatry 170 (8), pp.909-916. (10.1176/appi.ajp.2013.12081129)
• Hamshere, M. L. et al. 2013. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. British Journal of Psychiatry 203 (2), pp.107-111. (10.1192/bjp.bp.112.117432)
• Hamshere, M. L. et al. 2013. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Molecular Psychiatry 18 (6), pp.708-712. (10.1038/mp.2012.67)
• Heckers, S. et al., 2013. Structure of the psychotic disorders classification in DSM 5 [Review]. Schizophrenia Research 150 (1), pp.11-14. (10.1016/j.schres.2013.04.039)
• Hubers, A. A. et al., 2013. Suicidal ideation in a European Huntington's disease population. Journal of Affective Disorders 151 (1), pp.248-58. (10.1016/j.jad.2013.06.001)
• Kavanagh, D. et al., 2013. The ENCODE project: implications for psychiatric genetics. Molecular Psychiatry 18 (5), pp.540-542. (10.1038/mp.2013.13)
• Kim, Y. et al., 2013. Non-random mating, parent-of-origin, and maternal-fetal incompatibility effects in schizophrenia. Schizophrenia Research 143 (1), pp.11-17. (10.1016/j.schres.2012.11.002)
• Kirov, G. et al. 2013. The penetrance of copy number variations for schizophrenia and developmental delay. Biological Psychiatry 75 (5), pp.378-385. (10.1016/j.biopsych.2013.07.022)
• Kronenberg, F. et al., 2013. Novel Loci Associated with Increased Risk of Sudden Cardiac Death in the Context of Coronary Artery Disease [Article]. PLoS ONE 8 (4), pp.e59905. (10.1371/journal.pone.0059905)
• Lambert, J. C. et al., 2013. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease [Correction]. Molecular Psychiatry 18 (4), pp.521. (10.1038/mp.2012.75)
• Lambert, J. et al., 2013. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease [Letter]. Nature Genetics 45 (12), pp.1452-1458. (10.1038/ng.2802)
• Lee, S. et al., 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics 45 (9), pp.984-994. (10.1038/ng.2711)
• Majounie, E. et al. 2013. Variation in tau isoform expression in different brain regions and disease states. Neurobiology of Aging 34 (7), pp.1922.e7-1922.e12. (10.1016/j.neurobiolaging.2013.01.017)
• Malaspina, D. et al., 2013. Schizoaffective disorder in the DSM-5. Schizophrenia Research 150 (1), pp.21-25. (10.1016/j.schres.2013.04.026)
• Mars, B. et al., 2013. Specific parental depression symptoms as risk markers for new-onset depression in high-risk offspring. The Journal of Clinical Psychiatry 74 (09), pp.925-931. (10.4088/JCP.12m08152)
• Niarchou, M. et al. 2013. Defective processing speed and nonclinical psychotic experiences in children: longitudinal analyses in a large birth cohort. American Journal of Psychiatry 170 (5), pp.550-557. (10.1176/appi.ajp.2012.12060792)
• Peall, K. J. et al. 2013. SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain 136 (1), pp.294-303. (10.1093/brain/aws308)
• Power, R. A. et al., 2013. The interaction between child maltreatment, adult stressful life events and the 5-HTTLPR in major depression. Journal of Psychiatric Research 47 (8), pp.1032-1035. (10.1016/j.jpsychires.2013.03.017)
• Rees, E. et al. 2013. Evidence that duplications of 22q11.2 protect against schizophrenia. Molecular Psychiatry n/a (10.1038/mp.2013.156)
• Ripke, S. et al., 2013. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genetics 45 (10), pp.1150-1159. (10.1038/ng.2742)
• Rucker, J. J. H. et al., 2013. Genome-wide association analysis of copy number variation in recurrent depressive disorder. Molecular Psychiatry 18 , pp.183-189. (10.1038/mp.2011.144)
• Ruderfer, D. et al., 2013. Mosaic copy number variation in schizophrenia. European Journal of Human Genetics 21 (9), pp.1007-1011. (10.1038/ejhg.2012.287)
• Schosser, A. et al., 2013. Genome-wide association study of co-occurring anxiety in major depression. World Journal of Biological Psychiatry 14 (8), pp.611-21. (10.3109/15622975.2013.782107)
• Tandon, R. et al., 2013. Definition and description of schizophrenia in the DSM-5. Schizophrenia Research 150 (1), pp.3-10. (10.1016/j.schres.2013.05.028)
• Tandon, R. et al., 2013. Catatonia in DSM-5. Schizophrenia Research 150 (1), pp.26-30. (10.1016/j.schres.2013.04.034)
• Terwisscha van Scheltinga, A. F. et al., 2013. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biological Psychiatry 73 (6), pp.525-531. (10.1016/j.biopsych.2012.08.017)
• Tsuang, M. T. et al., 2013. Attenuated psychosis syndrome in DSM-5. Schizophrenia Research 150 (1), pp.31-5. (10.1016/j.schres.2013.05.004)
• van den Bree, M. B. et al. 2013. The internet is parents' main source of information about psychiatric manifestations of 22q11.2 deletion syndrome (22q11.2DS). European Journal of Medical Genetics 56 (8), pp.439-441. (10.1016/j.ejmg.2013.05.001)
• van Scheltinga, A. F. T. et al., 2013. Schizophrenia genetic variants are not associated with intelligence. Psychological Medicine 43 (12), pp.2563-2570. (10.1017/S0033291713000196)
• Walters, J. T. R. et al. 2013. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up. American Journal of Psychiatry 170 (8), pp.877-885. (10.1176/appi.ajp.2013.12020226)
• Williams, H. J. et al. 2013. Schizophrenia two-hit hypothesis in velo-cardio facial syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162 (2), pp.177-182. (10.1002/ajmg.b.32129)
• Yang, L. et al., 2013. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: Genome-wide association study of both common and rare variants. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162 (5), pp.419-430. (10.1002/ajmg.b.32169)
• Zammit, S. et al. 2013. A population-based study of genetic variation and psychotic experiences in adolescents. Schizophrenia Bulletin 40 (6), pp.1254-1262. (10.1093/schbul/sbt146)
• Zou, F. et al., 2013. Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's Disease pathology. PLoS ONE 8 (5) e64802. (10.1371/journal.pone.0064802)

2012

• Baig, S. et al., 2012. Clusterin mRNA and protein in Alzheimer's disease. Journal of Alzheimer's Disease 28 (2), pp.337-344. (10.3233/JAD-2011-110473)
• Cooper, J. D. et al., 2012. Seven newly identified loci for autoimmune thyroid disease. Human Molecular Genetics 21 (23), pp.5202-5208. (10.1093/hmg/dds357)
• Derks, E. M. et al., 2012. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: A polygenic risk score analysis. PLoS ONE 7 (6) e37852. (10.1371/journal.pone.0037852)
• Doherty, J. L. , O'Donovan, M. C. and Owen, M. J. 2012. Recent genomic advances in schizophrenia. Clinical Genetics 81 (2), pp.103-109. (10.1111/j.1399-0004.2011.01773.x)
• Economou, A. et al. 2012. The health informatics cohort enhancement project (HICE): using routinely collected primary care data to identify people with a lifetime diagnosis of psychotic disorder. BMC Research Notes 5 (1), pp.95-100. (10.1186/1756-0500-5-95)
• Escott-Price, V. et al. 2012. Permutation-based approaches do not adequately allow for linkage disequilibrium in gene-wide multi-locus association analysis. European Journal of Human Genetics 20 (8), pp.890-896. (10.1038/ejhg.2012.8)
• Eyre, S. et al., 2012. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nature Genetics 44 (12), pp.1336-1340. (10.1038/ng.2462)
• Fisher, H. L. et al., 2012. Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression. Journal of Affective Disorders 136 (1-2), pp.189-193. (10.1016/j.jad.2011.09.016)
• Fowler, T. et al., 2012. A population-based study of shared genetic variation between premorbid IQ and psychosis among male twin pairs and sibling pairs from Sweden. Archives of General Psychiatry 69 (5), pp.460-466. (10.1001/archgenpsychiatry.2011.1370)
• Fromer, M. et al., 2012. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. American Journal of Human Genetics 91 (4), pp.597-607. (10.1016/j.ajhg.2012.08.005)
• Gerrish, A. et al. 2012. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's Disease. Journal of Alzheimer's Disease 28 (2), pp.377-387. (10.3233/JAD-2011-110824)
• Grozeva, D. et al. 2012. Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophrenia Research 135 (1-3), pp.1-7. (10.1016/j.schres.2011.11.004)
• Hamilton, G. et al., 2012. The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 159B (6), pp.696-709. (10.1002/ajmg.b.32073)
• Hamilton, G. et al., 2012. Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus. Neurobiology of Aging 33 (8) 1848.e1. (10.1016/j.neurobiolaging.2012.02.005)
• Håvik, B. et al., 2012. DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder. PLoS ONE 7 (4), pp.e35424. (10.1371/journal.pone.0035424)
• Hollingworth, P. et al. 2012. Genome-wide association study of Alzheimer's disease with psychotic symptoms. Molecular Psychiatry 17 (12), pp.1316-1327. (10.1038/mp.2011.125)
• Hudson, G. et al., 2012. No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 78 (14), pp.1038-1042. (10.1212/WNL.0b013e31824e8f1d)
• Jia, P. et al., 2012. A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. Journal of Medical Genetics 49 (2), pp.96-103. (10.1136/jmedgenet-2011-100397)
• Jostins, L. et al., 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (7422), pp.119-124. (10.1038/nature11582)
• Keller, M. C. et al., 2012. Runs of homozygosity implicate autozygosity as a schizophrenia risk factor. Plos Genetics 8 (4) e1002656. (10.1371/journal.pgen.1002656)
• Kirov, G. et al. 2012. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Molecular Psychiatry 17 (2), pp.142-153. (10.1038/mp.2011.154)
• Lambert, J. C. et al., 2012. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Molecular Psychiatry 18 , pp.461-470. (10.1038/mp.2012.14)
• Levinson, D. F. et al., 2012. Genome-wide association study of multiplex schizophrenia pedigrees. American Journal of Psychiatry 169 (9), pp.963-973. (10.1176/appi.ajp.2012.11091423)
• O'Donovan, M. C. et al. 2012. Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biological psychiatry 72 (8), pp.620-628. (10.1016/j.biopsych.2012.05.035)
• Owen, M. J. 2012. Implications of genetic findings for understanding schizophrenia. Schizophrenia Bulletin 38 (5), pp.904-907. (10.1093/schbul/sbs103)
• Owen, M. J. 2012. Intellectual disability and major psychiatric disorders: a continuum of neurodevelopmental causality. British Journal of Psychiatry 200 (4), pp.268-269. (10.1192/bjp.bp.111.105551)
• Owen, M. J. 2012. The origins of schizophrenia [Review]. British Journal of Psychiatry 201 (2), pp.162. (10.1192/bjp.bp.111.107300)
• Peall, K. J. et al. 2012. Myoclonus dystonia syndrome: SGCE mutations and psychiatric disease [Abstract]. Journal of Neurology 259 , pp.S30-S30.
• Power, R. A. et al., 2012. Dissecting the genetic heterogeneity of depression through age at onset. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 159B (7), pp.859-868. (10.1002/ajmg.b.32093)
• Proitsi, P. et al., 2012. Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia. Neurobiology of Aging 33 (4), pp.791-803. (10.1016/j.neurobiolaging.2010.06.011)
• Rees, E. et al. 2012. De Novo mutation in schizophrenia. Schizophrenia Bulletin 38 (3), pp.377-381. (10.1093/schbul/sbs047)
• Richards, A. et al. 2012. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Molecular Psychiatry 17 (2), pp.193-201. (10.1038/mp.2011.11)
• Sellers, R. et al. 2012. Risk of psychopathology in adolescent offspring of mothers with psychopathology and recurrent depression. British Journal of Psychiatry 202 (2), pp.108-114. (10.1192/bjp.bp.111.104984)
• Shi, H. et al., 2012. Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS). Neurobiology of Aging 33 (8) 1849.e5. (10.1016/j.neurobiolaging.2012.02.014)
• Stergiakouli, E. et al. 2012. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. American Journal of Psychiatry 169 (2), pp.186-194. (10.1176/appi.ajp.2011.11040551)
• Sullivan, P. et al., 2012. Don't give up on GWAS [Letter]. Molecular Psychiatry 17 (1), pp.2-3. (10.1038/mp.2011.94)
• Thapar, A. K. et al. 2012. Trajectories of change in self-reported psychotic-like experiences in childhood and adolescence. Schizophrenia Research 140 (1-3), pp.104-109. (10.1016/j.schres.2012.06.024)
• Williams, H. J. et al. 2012. Absence of de novo point mutations in exons of GRIN2B in a large schizophrenia trio sample [Letter]. Schizophrenia Research 141 (2-3), pp.274-276. (10.1016/j.schres.2012.08.024)
• Williams, N. M. et al. 2012. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. American Journal of Psychiatry 169 (2), pp.195-204. (10.1176/appi.ajp.2011.11060822)

2011

• Belbin, O. et al., 2011. A multi-center study of ACE and the risk of late-onset Alzheimer's disease. Journal of Alzheimer's Disease 24 (3), pp.587-597. (10.3233/JAD-2011-101914)
• Boot, E. et al., 2011. COMT Val158met genotype and striatal D2/3 receptor binding in adults with 22q11 deletion syndrome. Synapse 65 (9), pp.967-970. (10.1002/syn.20932)
• Breen, G. et al., 2011. A genome-wide significant linkage for severe depression on chromosome 3: the depression network study. American Journal of Psychiatry 168 (8), pp.840-847. (10.1176/appi.ajp.2011.10091342)
• Bridges, M. et al., 2011. Genetic classification of populations using supervised learning. PLoS ONE 6 (5) e14802. (10.1371/journal.pone.0014802)
• Cardno, A. G. et al., 2011. A genomewide linkage study of age at onset in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156B (8), pp.929-940. (10.1002/ajmg.1404)
• Carroll, L. S. et al. 2011. Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 (7), pp.844-849. (10.1002/ajmg.b.31231)
• Chen, J. et al., 2011. Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia. Schizophrenia Research 131 (1-3), pp.43-51.
• Cichon, S. et al., 2011. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. American Journal of Human Genetics 88 (3), pp.372-381. (10.1016/j.ajhg.2011.01.017)
• Donohoe, G. et al., 2011. A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809 [Letter]. Schizophrenia Research 125 (2-3), pp.304-306. (10.1016/j.schres.2010.10.019)
• Dwyer, S. L. et al. 2011. Investigation of rare non-synonymous variants at ABCA13 in schizophrenia and bipolar disorder [letter]. Molecular Psychiatry 16 (8), pp.790-791. (10.1038/mp.2011.2)
• Escott-Price, V. et al. 2011. An examination of single nucleotide polymorphism selection prioritization strategies for tests of gene-gene interaction. Biological Psychiatry 70 (2), pp.198-203. (10.1016/j.biopsych.2011.01.034)
• Green, E. K. et al. 2011. DISC1 exon 11 rare variants found more commonly in schizoaffective spectrum cases than controls. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156B (4), pp.490-492. (10.1002/ajmg.b.31187)
• Hamshere, M. L. et al. 2011. Phenotype evaluation and genomewide linkage study of clinical variables in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 (8), pp.929-940. (10.1002/ajmg.b.31240)
• Hamshere, M. L. et al. 2011. Polygenic dissection of the bipolar phenotype. British Journal of Psychiatry 198 (4), pp.284-288. (10.1192/bjp.bp.110.087866)
• Hansen, T. et al., 2011. At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biological Psychiatry 70 (1), pp.59-63. (10.1016/j.biopsych.2011.01.031)
• Hinney, A. et al., 2011. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 (8), pp.888-897. (10.1002/ajmg.b.31246)
• Hollingworth, P. et al. 2011. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics 43 (5), pp.429-435. (10.1038/ng.803)
• Ikeda, M. et al., 2011. Genome-Wide Association Study of Schizophrenia in a Japanese Population. Biological Psychiatry 69 (5), pp.472-478. (10.1016/j.biopsych.2010.07.010)
• Ingason, A. et al., 2011. Maternally derived microduplications at 15q11-q13: Implication of imprinted genes in psychotic illness. American Journal of Psychiatry 168 (4), pp.408-417. (10.1176/appi.ajp.2010.09111660)
• Langley, K. et al. 2011. Clinical and cognitive characteristics of children with attention-deficit hyperactivity disorder, with and without copy number variants. British Journal of Psychiatry 199 (5), pp.398-403.
• Owen, M. J. 2011. Is there a schizophrenia to diagnose? [Editorial]. World Psychiatry 10 (1), pp.34-35. (10.1002/j.2051-5545.2011.tb00007.x)
• Owen, M. J. et al. 2011. Neurodevelopmental hypothesis of schizophrenia. British Journal of Psychiatry 198 (3), pp.173-175. (10.1192/bjp.bp.110.084384)
• Peall, K. J. et al. 2011. Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review. Movement Disorders 26 (10), pp.1939-1942. (10.1002/mds.23791)
• Proitsi, P. et al., 2011. A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD). Neurobiology of Aging 32 (3), pp.434-442. (10.1016/j.neurobiolaging.2009.03.005)
• Rees, E. et al. 2011. De novo rates and selection of schizophrenia-associated copy number variants. Biological Psychiatry 70 (12), pp.1109-1114. (10.1016/j.biopsych.2011.07.011)
• Reilly, M. P. et al., 2011. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. The Lancet 377 (9763), pp.383-392. (10.1016/S0140-6736(10)61996-4)
• Reitz, C. et al., 2011. Meta-analysis of the association between variants in SORL1 and Alzheimer Disease. Archives of Neurology 68 (1), pp.99-106. (10.1001/archneurol.2010.346)
• Rietschel, M. et al., 2011. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Molecular Psychiatry , pp.1-12. (10.1038/mp.2011.80)
• Ripke, S. et al., 2011. Genome-wide association study identifies five new schizophrenia loci [Letter]. Nature Genetics 43 (10), pp.969-976. (10.1038/ng.940)
• Rivera, M. et al., 2011. Depressive disorder moderates the effect of the FTO gene on body mass index. Molecular Psychiatry 17 (6), pp.604-611. (10.1038/mp.2011.45)
• Ruderfer, D. M. et al., 2011. A family-based study of common polygenic variation and risk of schizophrenia [Letter]. Molecular Psychiatry 16 (9), pp.887-888. (10.1038/mp.2011.34)
• Samaan, Z. et al., 2011. Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurology 11 , pp.66-74. (10.1186/1471-2377-11-66)
• Schosser, A. et al., 2011. A follow-up case-control association study of tractable (druggable) genes in recurrent major depression. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 (6), pp.640-650. (10.1002/ajmg.b.31204)
• Schosser, A. et al., 2011. P02-217 - COMT in major depression - UK candidate gene association study [Meeting Abstract]. European Psychiatry 26 , pp.813. (10.1016/S0924-9338(11)72518-4)
• Schosser, A. et al., 2011. Genomewide association scan of suicidal thoughts and behaviour in major depression. PLoS ONE 6 (7) e20690. (10.1371/journal.pone.0020690)
• Sims, R. et al. 2011. No evidence that extended tracts of homozygosity are associated with Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 (7), pp.764-771. (10.1002/ajmg.b.31216)
• Sklar, P. et al., 2011. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 [Letter]. Nature Genetics 43 (10), pp.977-983. (10.1038/ng.943)
• Smith, R. L. et al. 2011. Analysis of neurogranin (NRGN) in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156B (5), pp.532-535. (10.1002/ajmg.b.31191)
• Steinberg, S. et al., 2011. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human Molecular Genetics 20 (20), pp.4076-4081. (10.1093/hmg/ddr325)
• Stergiakouli, E. et al., 2011. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder. Genes Brain and Behavior 10 (3), pp.334-344. (10.1111/j.1601-183x.2010.00672.x)
• Williams, H. J. et al. 2011. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Human Molecular Genetics 20 (2), pp.387-391. (10.1093/hmg/ddq471)
• Williams, H. J. et al. 2011. Association between TCF4 and schizophrenia does not exert its effect by common nonsynonymous variation or by influencing cis-acting regulation of mRNA expression in adult human brain. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 (7), pp.781-784. (10.1002/ajmg.b.31219)
• Williams, H. J. et al. 2011. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Molecular Psychiatry 16 (4), pp.429-441. (10.1038/mp.2010.36)
• Williams, N. M. et al. 2011. Structural variations in attention-deficit hyperactivity disorder - Authors' reply [Letter]. The Lancet 377 (9763), pp.378. (10.1016/S0140-6736(11)60121-9)
• Yosifova, A. et al., 2011. Genome-wide association study on bipolar disorder in the Bulgarian population. Genes, Brain and Behavior 10 (7), pp.789-797. (10.1111/j.1601-183X.2011.00721.x)
• Zammit, S. et al. 2011. Cannabis, COMT and psychotic experiences. British Journal of Psychiatry 199 (5), pp.380-385. (10.1192/bjp.bp.111.091421)
• Zuliani, R. et al., 2011. Genetic variants in the ErbB4 gene are associated with white matter integrity. Psychiatry Research: Neuroimaging 191 (2), pp.133-137. (10.1016/j.pscychresns.2010.11.001)

2010

• Allison, D. B. et al., 2010. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genetics 6 (9) e1001097. (10.1371/journal.pgen.1001097)
• Baig, S. et al., 2010. Distribution and expression of picalm in alzheimer disease. Journal of Neuropathology and Experimental Neurology 69 (10), pp.1071-1077. (10.1097/NEN.0b013e3181f52e01)
• Blake, D. J. et al., 2010. TCF4, Schizophrenia, and Pitt-Hopkins Syndrome. Schizophrenia Bulletin 36 (3), pp.443-447. (10.1093/schbul/sbq035)
• Butler, A. W. et al., 2010. A genomewide linkage study on suicidality in major depressive disorder confirms evidence for linkage to 2p12. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (8), pp.1465-1473. (10.1002/ajmg.b.31127)
• Carroll, L. S. et al. 2010. Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha. Molecular Psychiatry 15 (11), pp.1101-1111. (10.1038/mp.2009.96)
• Chen, X. et al., 2010. GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Molecular Psychiatry 16 (11), pp.1117-1129. (10.1038/mp.2010.96)
• Cohen-Woods, S. et al., 2010. The Bipolar Association Case-Control Study (BACCS) and meta-analysis: No association with the 5,10-Methylenetetrahydrofolate reductase gene and bipolar disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (7), pp.1298-1304. (10.1002/ajmg.b.31101)
• Craddock, N. J. et al. 2010. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464 (7289), pp.713-720. (10.1038/nature08979)
• Craddock, N. J. et al. 2010. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Molecular Psychiatry 15 (2), pp.146-153. (10.1038/mp.2008.66)
• Craddock, N. J. et al. 2010. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype [Corrigendum]. Molecular Psychiatry 15 (11), pp.1121-1121. (10.1038/mp.2010.62)
• Craddock, N. J. and Owen, M. J. 2010. Authors' reply:. British Journal of Psychiatry 196 (6), pp.495-496. (10.1192/bjp.196.6.495a)
• Craddock, N. J. and Owen, M. J. 2010. Data and clinical utility should be the drivers of changes to psychiatric classification [Letter]. British Journal of Psychiatry 197 (2), pp.158. (10.1192/bjp.197.2.158)
• Craddock, N. J. and Owen, M. J. 2010. Molecular genetics and the kraepelinian dichotomy: one disorder, two disorders, or do we need to start thinking afresh?. Psychiatric Annals 40 (2), pp.88-91. (10.3928/00485718-20100127-04)
• Craddock, N. J. and Owen, M. J. 2010. Molecular genetics and the relationship between epilepsy and psychosis [Letter]. British Journal of Psychiatry 197 (1), pp.75-76. (10.1192/bjp.197.1.75a)
• Craddock, N. J. and Owen, M. J. 2010. The Kraepelinian dichotomy - going, going... but still not gone (Reappraisal). British Journal of Psychiatry 196 (2), pp.92-95. (10.1192/bjp.bp.109.073429)
• Cruchaga, C. et al., 2010. SNPS associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genetics 6 (9) e1001101. (10.1371/journal.pgen.1001101)
• Dwyer, S. L. et al. 2010. No evidence that rare coding variants in ZNF804A confer risk of schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (8), pp.1411-1416. (10.1002/ajmg.b.31117)
• Escott-Price, V. et al. 2010. Genetic differences between five European populations. Human Heredity 70 (2), pp.141-149. (10.1159/000313854)
• Green, E. K. et al. 2010. Variation at the GABAA receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (7), pp.1347-1349. (10.1002/ajmg.b.31108)
• Green, E. K. et al. 2010. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 15 (10), pp.1016-1022. (10.1038/mp.2009.49)
• Grozeva, D. et al. 2010. Rare copy number variants: A point of rarity in genetic risk for bipolar disorder and schizophrenia. Archives of General Psychiatry 67 (4), pp.318-327. (10.1001/archgenpsychiatry.2010.25)
• Hollingworth, P. et al. 2010. Alzheimer's disease genetics: current knowledge and future challenges. International Journal of Geriatric Psychiatry 26 (8), pp.793-802. (10.1002/gps.2628)
• Ikeda, M. et al. 2010. Copy number variation in schizophrenia in the Japanese population. Biological Psychiatry 67 (3), pp.283-286. (10.1016/j.biopsych.2009.08.034)
• Ikeda, M. et al. 2010. Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches. Biological psychiatry 67 (3), pp.263-269. (10.1016/j.biopsych.2009.08.030)
• Ikeda, M. et al. 2010. Failure to confirm association between PIK4CA and psychosis in 22q11.2 deletion syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (4), pp.980-982. (10.1002/ajmg.b.31060)
• Jones, L. et al. 2010. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS ONE 5 (11) e13950. (10.1371/journal.pone.0013950)
• Langley, K. et al. 2010. Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. British Journal of Psychiatry 196 (3), pp.235-240. (10.1192/bjp.bp.109.066274)
• Langley, K. et al. 2010. Genotype link with extreme antisocial behavior: The contribution of cognitive pathways. Archives of General Psychiatry 67 (12), pp.1317-1323. (10.1001/archgenpsychiatry.2010.163)
• Lewis, C. M. et al., 2010. Genome-wide association study of major recurrent depression in the U.K. population. American Journal of Psychiatry 167 (8), pp.949-957. (10.1176/appi.ajp.2010.09091380)
• Liu, Y. et al., 2010. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder [Letter]. Molecular Psychiatry 16 (1), pp.2-4. (10.1038/mp.2009.107)
• Lupton, M. K. et al., 2010. Education, occupation and retirement age effects on the age of onset of Alzheimer's disease. International Journal of Geriatric Psychiatry 25 (1), pp.30-36. (10.1002/gps.2294)
• Neale, B. M. et al., 2010. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 49 (9), pp.884-897. (10.1016/j.jaac.2010.06.008)
• Nishikawa, K. et al., 2010. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. The Journal of Clinical Investigation 120 (10), pp.3455-3465. (10.1172/JCI42528)
• Owen, M. J. , Craddock, N. J. and O'Donovan, M. C. 2010. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Archives of General Psychiatry 67 (7), pp.667-673. (10.1001/archgenpsychiatry.2010.69)
• Schosser, A. et al., 2010. Genome wide association scan of co-morbid anxiety in major depressive disorder (MDD) [Abstract]. International Journal of Psychiatry in Clinical Practice 14 (S1), pp.37.
• Seshadri, S. et al., 2010. Genome-wide analysis of genetic loci associated with Alzheimer Disease. JAMA - The Journal of the American Medical Association 303 (18), pp.1832-1840. (10.1001/jama.2010.574)
• Talkowski, M. E. et al., 2010. Fine-mapping reveals novel alternative splicing of the dopamine transporter. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (8), pp.1434-1447. (10.1002/ajmg.b.31125)
• Walters, J. T. R. et al. 2010. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Archives of General Psychiatry 67 (7), pp.692-700. (10.1001/archgenpsychiatry.2010.81)
• Williams, N. M. et al. 2010. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. The Lancet 376 (9750), pp.1401-1408. (10.1016/S0140-6736(10)61109-9)
• Zammit, S. , Owen, M. J. and Lewis, G. 2010. Misconceptions about gene-environment interactions in psychiatry. Evidence Based Mental Health 13 (3), pp.65-68. (10.1136/ebmh.13.3.65)

2009

• Abraham, R. A. et al. 2009. An association study of common variation at theMAPTlocus with late-onset Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B (8), pp.1152-1155. (10.1002/ajmg.b.30951)
• Azuma, R. et al., 2009. Visuospatial working memory in children and adolescents with 22q11.2 deletion syndrome; an fMRI study. Journal of Neurodevelopmental Disorders 1 (1), pp.46-60. (10.1007/s11689-009-9008-9)
• Betcheva, E. T. et al., 2009. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. Journal of Human Genetics 54 (2), pp.98-107. (10.1038/jhg.2008.14)
• Carroll, L. S. et al. 2009. Evidence that putative ADHD low risk alleles atSNAP25may increase the risk of schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B (7), pp.893-899. (10.1002/ajmg.b.30915)
• Cohen-Woods, S. et al., 2009. Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder. Human Molecular Genetics 18 (8), pp.1504-1509. (10.1093/hmg/ddp051)
• Craddock, N. J. , O'Donovan, M. C. and Owen, M. J. 2009. Psychosis genetics: modeling the relationship between Schizophrenia, Bipolar Disorder, and Mixed (or "Schizoaffective") Psychoses. Schizophrenia Bulletin 35 (3), pp.482-490. (10.1093/schbul/sbp020)
• Donohoe, G. et al., 2009. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Archives of General Psychiatry 66 (10), pp.1045-1054. (10.1001/archgenpsychiatry.2009.139)
• Dwyer, S. L. et al. 2009. Mutation screening of the DTNBP1 exonic sequence in 669 schizophrenics and 710 controls using high-resolution melting analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (3), pp.766-774. (10.1002/ajmg.b.31045)
• Escott-Price, V. et al. 2009. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Molecular Psychiatry 14 (3), pp.252-260. (10.1038/mp.2008.133)
• Fowler, T. A. et al. 2009. Psychopathy trait scores in adolescents with childhood ADHD: the contribution of genotypes affecting MAOA, 5HTT and COMT activity. Psychiatric Genetics 19 (6), pp.312-319. (10.1097/YPG.0b013e3283328df4)
• Fowler, T. A. et al. 2009. Psychopathy traits in adolescents with childhood attention-deficit hyperactivity disorder. British Journal of Psychiatry 194 (1), pp.62-67. (10.1192/bjp.bp.107.046870)
• Gerrish, A. et al. 2009. An examination of MUTED as a schizophrenia susceptibility gene [Letter]. Schizophrenia Research 107 (1), pp.110-111. (10.1016/j.schres.2008.08.011)
• Green, E. K. et al. 2009. P2RX7: A bipolar and unipolar disorder candidate susceptibility gene?. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B (8), pp.1063-1069. (10.1002/ajmg.b.30931)
• Hamshere, M. L. et al. 2009. Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. British Journal of Psychiatry 195 (1), pp.23-29. (10.1192/bjp.bp.108.061424)
• Hamshere, M. L. et al. 2009. Mood-incongruent psychosis in bipolar disorder: conditional linkage analysis shows genome-wide suggestive linkage at 1q32.3, 7p13 and 20q13.31. Bipolar Disorders 11 (6), pp.610-620. (10.1111/j.1399-5618.2009.00736.x)
• Harold, D. et al. 2009. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease [Corrigendum]. Nature Genetics 41 (10), pp.1156. (10.1038/ng1009-1156d)
• Harold, D. et al. 2009. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease [Letter]. Nature Genetics 41 (10), pp.1088-1093. (10.1038/ng.440)
• Hayesmoore, J. B. G. et al. 2009. The effect of age and the H1c MAPT haplotype on MAPT expression in human brain. Neurobiology of Aging 30 (10), pp.1652-1656. (10.1016/j.neurobiolaging.2007.12.017)
• Holmans, P. A. et al. 2009. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. American Journal of Human Genetics 85 (1), pp.13-24. (10.1016/j.ajhg.2009.05.011)
• Holmans, P. A. et al. 2009. Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. Molecular Psychiatry 14 (8), pp.786-795. (10.1038/mp.2009.11)
• Ingason, A. et al., 2009. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Human Molecular Genetics 19 (7), pp.1379-1386. (10.1093/hmg/ddq009)
• Kauwe, J. S. K. et al., 2009. Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (4), pp.955-959. (10.1002/ajmg.b.31053)
• Kirov, G. et al. 2009. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Human Molecular Genetics 18 (8), pp.1497-1503. (10.1093/hmg/ddp043)
• Kirov, G. and Owen, M. J. 2009. Genetics of schizophrenia. In: Sadock, B. J. , Sadock, V. A. and Ruiz, P. eds. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. 9th ed.. Vol. 1, Philadelphia: Lippincott Williams and Wilkins. , pp.1462-1474.
• Kirov, G. et al. 2009. Neurexin 1 (NRXN1) deletions in Schizophrenia. Schizophrenia Bulletin 35 (5), pp.851-854. (10.1093/schbul/sbp079)
• Langley, K. et al. 2009. Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder. European Child & Adolescent Psychiatry 18 (1), pp.26-32. (10.1007/s00787-008-0698-4)
• Li, Y. et al., 2009. An international collaborative family-based whole-genome linkage scan for high-grade myopia. Investigative Ophthalmology & Visual Science 50 (7), pp.3116-3127. (10.1167/iovs.08-2781)
• McCarthy, S. E. et al., 2009. Microduplications of 16p11.2 are associated with schizophrenia. Nature Genetics 41 (11), pp.1223-1227. (10.1038/ng.474)
• Metlapally, R. et al., 2009. COL1A1 and COL2A1 genes and myopia susceptibility: evidence of association and suggestive linkage to the COL2A1 locus. Investigative Ophthalmology and Visual Science 50 (9), pp.4080-4086. (10.1167/iovs.08-3346)
• Morgan, A. R. et al. 2009. Association analysis of dynamin-binding protein (DNMBP) on chromosome 10q with late onset Alzheimer's disease in a large caucasian UK sample. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B (1), pp.61-64. (10.1002/ajmg.b.30768)
• O'Donovan, M. C. , Craddock, N. J. and Owen, M. J. 2009. Genetics of psychosis; insights from views across the genome. Human Genetics 126 (1), pp.3-12. (10.1007/s00439-009-0703-0)
• O'Donovan, M. C. , Craddock, N. J. and Owen, M. J. 2009. Strong evidence for multiple psychosis susceptibility genes - a rejoinder to Crow [Letter]. Psychological Medicine 39 (1), pp.170-171. (10.1017/S0033291708004583)
• O'Donovan, M. C. et al. 2009. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Molecular Psychiatry 14 (1), pp.30-36. (10.1038/mp.2008.108)
• O'Donovan, M. C. and Owen, M. J. 2009. Genetics and the brain: many pathways to enlightenment [Editorial]. Human Genetics 126 (1), pp.1-2. (10.1007/s00439-009-0705-y)
• Owen, M. J. 2009. Will schizophrenia become a graveyard for molecular geneticists?. Psychological Medicine 22 (02), pp.289-293. (10.1017/S0033291700030221)
• Owen, M. J. and Craddock, N. J. 2009. Diagnosis of functional psychoses: time to face the future [Comment]. The Lancet 373 (9659), pp.190-191. (10.1016/S0140-6736(09)60053-2)
• Owen, M. J. , Williams, H. J. and O'Donovan, M. C. 2009. Schizophrenia genetics: advancing on two fronts. Current Opinion in Genetics & Development 19 (3), pp.266-270. (10.1016/j.gde.2009.02.008)
• Purcell, S. M. et al., 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460 (7256), pp.748-752. (10.1038/nature08185)
• Samaan, Z. et al., 2009. Migraine in recurrent depression: case-control study (Paper). British Journal of Psychiatry 194 (4), pp.350-354. (10.1192/bjp.bp.108.054049)
• Schosser, A. et al., 2009. NRG1gene in recurrent major depression: No association in a large-scale case-control association study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B (1), pp.141-147. (10.1002/ajmg.b.30965)
• Schosser, A. et al., 2009. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies. Molecular Psychiatry 15 (8), pp.844-849. (10.1038/mp.2009.21)
• Sims, R. et al. 2009. Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease. Neuroscience Letters 461 (1), pp.54-59. (10.1016/j.neulet.2009.05.051)
• Smith, D. J. , Owen, M. J. and Craddock, N. J. 2009. Bipolar disorder and unipolar depression: what is the genetic relationship?. In: Pariante, C. M. et al., Understanding Depression: a Translational Approach. Oxford: Oxford University Press. , pp.67-76.
• Talkowski, M. E. et al., 2009. Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B (4), pp.560-569. (10.1002/ajmg.b.30862)
• Williams, H. J. , Owen, M. J. and O'Donovan, M. C. 2009. New findings from genetic association studies of schizophrenia. Journal of Human Genetics 54 (1), pp.9-14. (10.1038/jhg.2008.7)
• Yosifova, A. et al., 2009. Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. Journal of Affective Disorders 117 (1-2), pp.87-97. (10.1016/j.jad.2008.12.021)

2008

• Blom, E. S. et al., 2008. Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B (6), pp.778-783. (10.1002/ajmg.b.30681)
• Bray, N. J. et al. 2008. Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1. Human Molecular Genetics 17 (8), pp.1169-1174. (10.1093/hmg/ddn006)
• Buxbaum, J. D. et al., 2008. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Molecular psychiatry 13 , pp.162-172. (10.1038/sj.mp.4001991)
• Caspi, A. et al., 2008. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry 65 (2), pp.203-210. (10.1001/archgenpsychiatry.2007.24)
• Craddock, N. J. et al. 2008. Authors' reply. The British Journal of Psychiatry 193 (6), pp.517. (10.1192/bjp.193.6.517)
• Craddock, N. J. et al. 2008. Wake-up call for British psychiatry. British Journal of Psychiatry 193 (1), pp.6-9. (10.1192/bjp.bp.108.053561)
• Craddock, N. J. et al. 2008. Wake up call: Response from authors [eLetter]. British Journal of Psychiatry
• Craddock, N. J. , O'Donovan, M. C. and Owen, M. J. 2008. Genome-wide association studies in psychiatry: lessons from early studies of non-psychiatric and psychiatric phenotypes [Guest Editorial]. Molecular Psychiatry 13 (7), pp.649-653. (10.1038/mp.2008.45)
• Farmer, A. et al., 2008. Medical disorders in people with recurrent depression. The British Journal of Psychiatry 192 (5), pp.351-355. (10.1192/bjp.bp.107.038380)
• Ferreira, M. A. R. et al., 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics 40 (9), pp.1056-1058. (10.1038/ng.209)
• Gaysina, D. et al., 2008. No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: Results of the depression case control (DeCC) study and a meta-analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B (6), pp.699-706. (10.1002/ajmg.b.30665)
• Georgieva, L. et al. 2008. Support for Neuregulin 1 as a susceptibility gene for Bipolar disorder and schizophrenia. Biological psychiatry 64 (5), pp.419-427. (10.1016/j.biopsych.2008.03.025)
• Hayesmoore, J. B. et al. 2008. DISC1mRNA expression is not influenced by common Cis-acting regulatory polymorphisms or imprinting.. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B (7), pp.1065-1069. (10.1002/ajmg.b.30715)
• Kirov, G. et al. 2008. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Human Molecular Genetics 17 (3), pp.458-465. (10.1093/hmg/ddm323)
• Kirov, G. et al. 2008. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Molecular Psychiatry 14 (8), pp.796-803. (10.1038/mp.2008.33)
• Krystal, J. H. et al., 2008. It is time to take a stand for medical research and against terrorism targeting medical scientists. Biological Psychiatry 63 (8), pp.725-727. (10.1016/j.biopsych.2008.03.005)
• Kwok, J. B. J. et al., 2008. Glycogen synthase kinase-3β and tau genes interact in Alzheimer's disease. Annals of Neurology 64 (4), pp.446-454. (10.1002/ana.21476)
• Langley, K. et al. 2008. Testing for gene × environment interaction effects in attention deficit hyperactivity disorder and associated antisocial behavior. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B (1), pp.49-53. (10.1002/ajmg.b.30571)
• Li, H. et al., 2008. Candidate single-nucleotide polymorphisms from a genomewide association study of alzheimer disease. Archives of Neurology 65 (1), pp.45-53. (10.1001/archneurol.2007.3)
• Li, Y. et al., 2008. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Human Molecular Genetics 17 (5), pp.759-767. (10.1093/hmg/ddm348)
• Li, Y. et al., 2008. SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiology of Disease 29 (2), pp.293-296. (10.1016/j.nbd.2007.09.001)
• O'Donovan, M. C. et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics 40 (9), pp.1053-1055. (10.1038/ng.201)
• O'Donovan, M. C. , Craddock, N. J. and Owen, M. J. 2008. Schizophrenia: complex genetics, not fairy tales. Psychological Medicine 38 (12), pp.1697-1699. (10.1017/S0033291708003802)
• O'Donovan, M. C. , Kirov, G. and Owen, M. J. 2008. Phenotypic variations on the theme of CNVs. Nature Genetics 40 (12), pp.1392-1393. (10.1038/ng1208-1392)
• Richards, A. L. et al. 2008. A comparison of four clustering methods for brain expression microarray data. BMC Bioinformatics 9 490. (10.1186/1471-2105-9-490)
• Shifman, S. et al., 2008. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLOS Genetics 4 (2) e28. (10.1371/journal.pgen.0040028)
• Stone, J. L. et al., 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 (7210), pp.237-241. (10.1038/nature07239)
• Thapar, A. and Owen, M. J. 2008. A framework for interpreting genome-wide association studies of psychiatric disorders. Molecular Psychiatry 14 (1), pp.10-17. (10.1038/mp.2008.126)
• van Amelsvoort, T. et al., 2008. Effects of a functional COMT polymorphism on brain anatomy and cognitive function in adults with velo-cardio-facial syndrome. Psychological Medicine 38 (1), pp.89-100. (10.1017/S0033291707000700)
• Williams, N. M. et al. 2008. Strong evidence that GNB1L is associated with schizophrenia. Human Molecular Genetics 17 (4), pp.555-566. (10.1093/hmg/ddm330)
• Williams, N. M. et al. 2008. Analysis of copy number variation using quantitative interspecies competitive PCR. Nucleic Acids Research 36 (17), pp.e112-e112. (10.1093/nar/gkn495)

2007

• Burton, P. R. et al., 2007. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 39 (11), pp.1329-1337. (10.1038/ng.2007.17)
• Craddock, N. J. , O'Donovan, M. C. and Owen, M. J. 2007. Phenotypic and genetic complexity of psychosis Invited commentary on ... Schizophrenia: a common disease caused by multiple rare alleles. British Journal of Psychiatry 190 (3), pp.200-203. (10.1192/bjp.bp.106.033761)
• Craddock, N. J. , O'Donovan, M. C. and Owen, M. J. 2007. Symptom dimensions and the Kraepelinian dichotomy. British Journal of Psychiatry 190 (4), pp.361. (10.1192/bjp.190.4.361)
• Craddock, N. J. and Owen, M. J. 2007. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry 6 (2), pp.84-91.
• Grupe, A. et al., 2007. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Human Molecular Genetics 16 (8), pp.865-873. (10.1093/hmg/ddm031)
• Hamshere, M. L. et al. 2007. Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease. Human Molecular Genetics Advanc , pp.1-34. (10.1093/hmg/ddm224)
• Jones, I. R. et al. 2007. Bipolar affective puerperal psychosis: genome-wide significant evidence for linkage to chromosome 16. American journal of psychiatry 164 (7), pp.1099-1104. (10.1176/appi.ajp.164.7.1099)
• Morgan, A. et al., 2007. Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B (6), pp.727-731. (10.1002/ajmg.b.30670)
• Rice, F. et al. 2007. Agreement between maternal report and antenatal records for a range of pre and peri-natal factors: The influence of maternal and child characteristics. Early Human Development 83 (8), pp.497-504. (10.1016/j.earlhumdev.2006.09.015)
• Talkowski, M. E. et al., 2007. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Human Molecular Genetics 17 (5), pp.747-758. (10.1093/hmg/ddm347)
• Thapar, A. et al. 2007. Promoting Measured Genes and Measured Environments: On the Importance of Careful Statistical Analyses and Biological Relevance—Reply [Letter]. Archives of General Psychiatry 64 (3), pp.378-379. (10.1001/archpsyc.64.3.378-b)

2006

• Blair, I. P. et al., 2006. Positional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Molecular Psychiatry 11 (4), pp.372-383. (10.1038/sj.mp.4001784)
• Craddock, N. J. , Owen, M. J. and O'Donovan, M. C. 2006. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Molecular Psychiatry 11 (5), pp.446-458. (10.1038/sj.mp.4001808)
• Escott-Price, V. et al. 2006. Effects of differential genotyping error rate on the Type 1 error probability of case-control studies. Human heredity 61 (1), pp.55-64. (10.1159/000092553)
• Georgieva, L. et al. 2006. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America (PNAS) ISSN 1091-6490 103 (33), pp.12469-12474. (10.1073/pnas.0603029103)
• Green, E. K. et al., 2006. Evidence that a DISC1 frame-shift deletion associated with psychosis in a single family may not be a pathogenic mutation. Molecular Psychiatry 11 (9), pp.798-799. (10.1038/sj.mp.4001853)
• Green, E. K. et al., 2006. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. British Journal of Psychiatry 188 (1), pp.21-25. (10.1192/bjp.bp.105.009969)
• Grupe, A. et al., 2006. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. The American Journal of Human Genetics 78 (1), pp.78-88.
• Hamshere, M. L. et al. 2006. Genome wide significant linkage in schizophrenia conditioning on occurrence of depressive episodes. Journal of Medical Genetics 43 (7), pp.563-567. (10.1136/jmg.2005.035345)
• Kirov, G. et al. 2006. Pooled DNA genotyping on Affymetrix SNP genotyping arrays. BMC Genomics 7 (1), pp.27-37. (10.1186/1471-2164-7-27)
• Lambert, D. et al., 2006. Stage 2 of the Wellcome Trust UK–Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16–q21, 4q12–q21, 9p21, 10p14–p12 and 18q22 - Corrigendum. Molecular Psychiatry 11 (12), pp.1140-1143. (10.1038/sj.mp.4001917)
• Norton, N. et al. 2006. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141B (1), pp.96-101. (10.1002/ajmg.b.30236)
• Peirce, T. R. et al. 2006. Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. Archives of general psychiatry 63 (1), pp.18-24. (10.1001/archpsyc.63.1.18)
• Rees, M. I. et al. 2006. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nature genetics 38 (7), pp.801-806. (10.1038/ng1814)
• Williams, N. M. et al. 2006. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Archives of General Psychiatry 63 (4), pp.366-373. (10.1001/archpsyc.63.4.366)

2005

• Bray, N. J. et al. 2005. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Human Molecular Genetics 14 (14), pp.1947-1954. (10.1093/hmg/ddi199)
• Cope, N. A. et al., 2005. Strong evidence that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia. American Journal of Human Genetics 76 (4), pp.581-591. (10.1086/429131)
• Craddock, N. J. , O'Donovan, M. C. and Owen, M. J. 2005. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bulletin 32 (1), pp.9-16. (10.1093/schbul/sbj033)
• Craddock, N. J. , O'Donovan, M. C. and Owen, M. J. 2005. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. Journal of Medical Genetics 42 (3), pp.193-204. (10.1136/jmg.2005.030718)
• Escott-Price, V. et al. 2005. Streamlined analysis of pooled genotype data in SNP-based association studies. Genetic Epidemiology 28 (3), pp.273-282. (10.1002/gepi.20062)
• Glaser, B. et al., 2005. Identification of a potential Bipolar risk haplotype in the gene encoding the winged-helix transcription factor RFX4. Molecular Psychiatry 10 (10), pp.920-927. (10.1038/sj.mp.4001689)
• Green, E. et al., 2005. Localization of bipolar susceptibility locus by molecular genetic analysis of the chromosome 12q23-q24 region in two pedigrees with bipolar disorder and Darier's disease. American Journal of Psychiatry 162 (1), pp.35-42. (10.1176/appi.ajp.162.1.35)
• Green, E. K. et al. 2005. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Archives of general psychiatry 62 (6), pp.642-648. (10.1001/archpsyc.62.6.642)
• Hamshere, M. L. et al. 2005. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Archives of general psychiatry 62 (10), pp.1081-1088. (10.1001/archpsyc.62.10.1081)
• Kent, L. et al., 2005. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Molecular Psychiatry 10 (10), pp.939-943. (10.1038/sj.mp.4001696)
• Lambert, D. et al., 2005. Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Molecular psychiatry 10 (9), pp.831-841. (10.1038/sj.mp.4001684)
• McGuffin, P. et al., 2005. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Human Molecular Genetics 14 (22), pp.3337-3345. (10.1093/hmg/ddi363)
• Owen, M. J. , Craddock, N. J. and O'Donovan, M. C. 2005. Schizophrenia: genes at last?. Trends in Genetics 21 (9), pp.518-525. (10.1016/j.tig.2005.06.011)
• Raybould, R. et al. 2005. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biological psychiatry 57 (7), pp.696-701. (10.1016/j.biopsych.2005.01.018)
• Thapar, A. et al. 2005. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry 62 (11), pp.1275-1278. (10.1001/archpsyc.62.11.1275)

2004

• Bray, N. J. et al. 2004. The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Molecular Psychiatry 9 (1), pp.109-114. (10.1038/sj.mp.4001366)
• Bray, N. J. et al. 2004. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Human Molecular Genetics 13 (22), pp.2885-2892. (10.1093/hmg/ddh299)
• Cichon, S. et al., 2004. Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nature Genetics 36 (8), pp.783-784. (10.1038/ng0804-783)
• Farbrother, J. E. et al., 2004. Family aggregation of high myopia: estimation of the sibling recurrence risk ratio. Investigative Ophthalmology and Visual Science 45 (9), pp.2873-2878. (10.1167/iovs.03-1155)
• Farbrother, J. E. et al., 2004. Linkage analysis of the genetic loci for high myopia on chromosomes 18p, 12q and 17q in 51 UK families. Investigative Ophthalmology and Visual Science 45 (9), pp.2879-2885. (10.1167/iovs.03-1156)
• Farmer, A. et al., 2004. The Depression Network (DeNT) Study: methodology and sociodemographic characteristics of the first 470 affected sibling pairs from a large multi-site linkage genetic study. BMC Psychiatry 4 42. (10.1186/1471-244X-4-42)
• Fowler, T. A. et al., 2004. Early onset antisocial behaviour in children with ADHD is associated with a functional variant in the catechol-O-methyltransferase (COMT) gene [Abstract]. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 130B (1), pp.98-98. (10.1002/ajmg.b.30101)
• Harvey, K. et al., 2004. The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. Journal of neuroscience 24 (25), pp.5816-5826. (10.1523/JNEUROSCI.1184-04.2004)
• Kirov, G. et al. 2004. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biological psychiatry 55 (10), pp.971-975. (10.1016/j.biopsych.2004.01.025)
• Korszun, A. et al., 2004. Familiarity of symptom dimensions in depression. Archives of General Psychiatry 61 (5), pp.468-474. (10.1001/archpsyc.61.5.468)
• Langley, K. et al. 2004. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. American Journal of Psychiatry 161 (1), pp.133-138. (10.1176/appi.ajp.161.1.133)
• Li, Y. et al., 2004. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proceedings of the National Academy of Sciences 101 (44), pp.15688-15693. (10.1073/pnas.0403535101)
• Turic, D. et al. 2004. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Molecular Psychiatry 9 (2), pp.169-173. (10.1038/sj.mp.4001387)
• Williams, N. M. et al. 2004. Identification in two independent samples of a novel schizophrenia risk haplotype of the dystobrevin binding protein gene (DTNBP1). Archives of general psychiatry 61 (4), pp.336-344. (10.1001/archpsyc.61.4.336)
• Williams, N. M. et al. 2004. Support for RGS4 as a susceptibility gene for schizophrenia. Biological Psychiatry 55 (2), pp.192-195. (10.1016/j.biopsych.2003.11.002)

2003

• Bray, N. B. et al. 2003. Cis-acting variation in the expression of a high proportion of genes in human brain. Human Genetics 113 (2), pp.149-153. (10.1007/s00439-003-0956-y)
• Bray, N. J. et al. 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. The American Journal of Human Genetics 73 (1), pp.152-161. (10.1086/376578)
• Børglum, A. et al., 2003. Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder. American Journal of Medical Genetics 117B (1), pp.18-22. (10.1002/ajmg.b.10030)
• Farbrother, J. E. et al., 2003. Linkage analysis of 18p, 12q and 17q high myopia loci in 51 UK families. Investigative ophthalmology & visual science 44 (E-Abst)
• Green, E. K. et al., 2003. Mutational analysis of two positional candidate susceptibility genes for bipolar disorder on chromosome 12q23-q24: phenylalanine hydroxylase and human LIM-homeobox LHX5. Psychiatric Genetics 13 (2), pp.97-101. (10.1097/01.ypg.0000057882.80011.9e)
• Heron, J. et al., 2003. Self-reported schizotypy and bipolar disorder: demonstration of a lack of specificity of the Kings Schizotypy Questionnaire. Schizophrenia Research 65 (2-3), pp.153-158. (10.1016/S0920-9964(03)00004-5)
• Ivanov, D. et al. 2003. Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis: Molecular genetic study. The British Journal of Psychiatry 183 (5), pp.409-413. (10.1192/bjp.183.5.409)
• Jordan, N. et al., 2003. The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a Caucasian population. Journal of Clinical Endocrinology & Metabolism 88 (3), pp.1002-5. (10.1210/jc.2002-021301)
• O'Donovan, M. C. and Owen, M. J. 2003. Genetic findings in psychotic disorders. In: Soares, J. C. and Gershon, S. eds. Handbook of Medical Psychiatry. New York: Marcel Dekker. , pp.417-432.
• Owen, M. J. and O'Donovan, M. C. 2003. Schizophrenia and genetics. In: Plomin, R. et al., Behavioral Genetics in the Postgenomic Era. Washington, DC: APA Books. , pp.463-480. (10.1037/10480-023)
• Rees, M. I. et al., 2003. Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. Journal of Biological Chemistry 278 (27), pp.24688-24696. (10.1074/jbc.M301070200)
• Williams, N. M. et al. 2003. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. The American journal of human genetics 73 (6), pp.1355-1367. (10.1086/380206)

2002

• Anney, R. et al. 2002. Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia. Molecular psychiatry 7 (5), pp.493-502. (10.1038/sj.mp.4001003)
• Bennett, P. et al., 2002. The Wellcome trust UK-Irish bipolar affective disorder sibling-pair genome screen: first stage report. Molecular Psychiatry 7 (2), pp.189-200. (10.1038/sj.mp.4000957)
• Holmes, J. et al., 2002. Association of DRD4 in children with ADHD and comorbid conduct problems. American Journal of Medical Genetics 114 (2), pp.150-153. (10.1002/ajmg.10149)
• Jones, I. R. et al. 2002. Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease. Molecular psychiatry 7 (4), pp.424-427. (10.1038/sj.mp.4000989)
• Levinson, D. F. et al., 2002. No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 296 (5568), pp.739-741. (10.1126/science.1069914)
• Rees, M. I. et al. 2002. Hyperekplexia associated with compound heterozygote mutations in the β-subunit of the human inhibitory glycine receptor (GLRB). Human Molecular Genetics 11 (7), pp.853-860. (10.1093/hmg/11.7.853)
• Scourfield, J. and Owen, M. J. 2002. Genetic counselling. In: McGuffin, P. , Owen, M. J. and Gottesman, I. I. eds. Psychiatric Genetics and Genomics. Oxford Medical Publications Oxford: Oxford University Press. , pp.415-424.
• Sklar, P. et al., 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Molecular Psychiatry 7 (6), pp.579. (10.1038/sj.mp.4001058)
• Tsuang, M. T. and Owen, M. J. 2002. Molecular and population genetics of schizophrenia. In: Davis, K. L. et al., Neuropsychopharmacology - 5th Generation of Progress. Philadelphia, PA: Lippincott, Williams and Wilkins. , pp.671-687.
• West, A. et al., 2002. Evidence to suggest biased phenotypes in children with Attention Deficit Hyperactivity Disorder from completely ascertained trios. Molecular Psychiatry 7 (9), pp.962-966. (10.1038/sj.mp.4001129)
• Williams, N. M. et al. 2002. Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Molecular Psychiatry 7 (5), pp.508-514. (10.1038/sj.mp.4001030)
• Williams, N. M. et al. 2002. Mutation screening and LD mapping in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach. Molecular Psychiatry 7 (10), pp.1092-1100. (10.1038/sj.mp.4001188)
• Zammit, S. , O'Donovan, M. C. and Owen, M. J. 2002. Neurogenetics of schizophrenia. In: D'haenen, H. , den Boer, J. A. and Willner, P. eds. Biological Psychiatry. Chichester: Wiley. , pp.663-671. (10.1002/0470854871.chxvii9)

2001

• Bowen, T. et al. 2001. Mutation screening of the KCNN3 gene reveals a rare frameshift mutation [Letter]. Molecular Psychiatry 6 (3), pp.259-260. (10.1038/sj.mp.4000128)
• Bray, N. J. and Owen, M. J. 2001. Searching for schizophrenia genes. Trends in Molecular Medicine 7 (4), pp.169-174.
• Campbell, L. E. et al., 2001. Neuropsychological profile of children with Velo-cardio-facial syndrome (VCFS). Journal of Medical Genetics 38 , pp.S39-S39.
• Elvidge, G. et al., 2001. Allelic variation of aBalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: Results of analysis and meta-analysis. American Journal of Medical Genetics 105 (4), pp.307-311. (10.1002/ajmg.1353)
• Hamshere, M. L. et al. 2001. Statistical analysis of genotypic association data with HAPMAXII. AMERICAN JOURNAL OF HUMAN GENETICS 69 (4), pp.390-390.
• Jacobsen, N. J. O. et al., 2001. Exclusion of the Darier's disease gene, ATP2A2, as a common susceptibility gene for bipolar disorder. Molecular Psychiatry 6 (1), pp.92-97. (10.1038/sj.mp.4000774)
• Jacobsen, N. J. O. et al., 2001. CUX2, a potential regulator of NCAM expression: Genomic characterization and analysis as a positional candidate susceptibility gene for bipolar disorder. American Journal of Medical Genetics 105 (3), pp.295-300. (10.1002/ajmg.1325)
• Jones, G. et al. 2001. Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. British Journal of Psychiatry 179 (4), pp.351-355. (10.1192/bjp.179.4.351)
• Jones, L. A. et al., 2001. Sustained and selective attention as measures of genetic liability to schizophrenia. Schizophrenia Research 48 (2-3), pp.263-267.
• Liddell, M. , Lovestone, S. and Owen, M. J. 2001. Advising relatives of risk of Alzheimer's disease - Authors' reply. British Journal of Psychiatry 179 (1), pp.73-74. (10.1192/bjp.179.1.73)
• Liddell, M. B. , Lovestone, S. and Owen, M. J. 2001. Genetic risk of Alzheimer's disease: advising relatives. British Journal of Psychiatry 178 (1), pp.7-11. (10.1192/bjp.178.1.7)
• Owen, M. J. 2001. Simple and complex genetics of Alzheimer's disease. Journal of Medical Genetics 38 , pp.S29-S29.
• Payton, A. et al., 2001. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Neuroscience Letters 105 (5), pp.464-470. (10.1002/ajmg.1407)
• Rees, M. I. et al., 2001. A missense mutation of human Gephyrin (GPHN) is associated with Hyperekplexia and transcript isoform analysis re-defines the genomic structure of GPHN. American Journal of Human Genetics 69 (4), pp.627-627.
• Rees, M. I. et al., 2001. Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia. Hum Genet 109 (3), pp.267-270.
• Turic, D. et al., 2001. No association between apolipoprotein E polymorphisms and general cognitive ability in children. Neuroscience Letters 299 (1-2), pp.97-100. (10.1016/S0304-3940(00)01789-4)
• van Amelsvoort, T. et al., 2001. Structural brain abnormalities associated with deletion at chromosome 22q11. British Journal of Psychiatry (178), pp.412-419. (10.1192/bjp.178.5.412)
• Wang, E. C. Y. et al. 2001. Genomic structure, expression, and chromosome mapping of the mouse homologue for the WSL-1 (DR3, Apo3, TRAMP, LARD, TR3, TNFRSF12) gene. Immunogenetics 53 (1), pp.59-63. (10.1007/s002510000290)
• Wang, E. C. Y. et al. 2001. DR3 regulates negative selection during thymocyte development. Molecular and cellular biology 21 (10), pp.3451-61. (10.1128/MCB.21.10.3451-3461.2001)
• Wickham, H. et al., 2001. Familiality of symptom dimensions in schizophrenia. Schizophrenia Research 47 (2-3), pp.223-232. (10.1016/S0920-9964(00)00098-0)

2000

• Austin, J. et al., 2000. The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia. Molecular Psychiatry 5 (5), pp.552-557. (10.1038/sj.mp.4000761)
• Austin, J. et al., 2000. Association analysis of the proneurotensin gene and bipolar disorder. Psychiatric Genetics 10 (1), pp.51-54. (10.1097/00041444-200010010-00009)
• Austin, J. et al., 2000. Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Molecular Psychiatry 5 (2), pp.208-212. (10.1038/sj.mp.4000693)
• Bowen, T. et al. 2000. No evidence of association from transmission disequilibrium analysis of the hKCa3 gene in bipolar disorder. Bipolar Disorders 2 (4), pp.328-331. (10.1034/j.1399-5618.2000.020406.x)
• Bowen, T. et al. 2000. Repeat sizes at CAG/CTG loci CTG18.1, ERDA1 and TGC13-7a in schizophrenia. Psychiatric Genetics 10 (1), pp.33-37. (10.1097/00041444-200010010-00006)
• Bray, N. J. et al. 2000. No evidence for association between a non-synonymous polymorphism in the gene encoding human metabotropic glutamate receptor 7 and schizophrenia. Psychiatric Genetics 10 (2), pp.83-86. (10.1097/00041444-200010020-00005)
• Fitzpatrick, E. et al., 2000. Association studies of polymorphisms in the promoter region of the dopamine D4 receptor and the D2 receptor [Abstract]. American Journal of Medical Genetics 96 (4), pp.530-530. (10.1002/1096-8628(20000807)96:4<515::AID-AJMG6>3.0.CO;2-U)
• Hoogendoorn, B. et al. 2000. Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Human Genetics 107 (5), pp.488-493. (10.1007/s004390000397)
• Kirov, G. et al. 2000. Pooled genotyping of microsatellite markers in parent-offspring trios. Genome Research 10 (1), pp.105-115.
• Middle, F. et al., 2000. Bipolar disorder and variation at a common polymorphism (A1832G) within exon 8 of the Wolfram gene. American Journal of Medical Genetics 96 (2), pp.154-157. (10.1002/(sici)1096-8628(20000403)96:2%3C154::aid-ajmg5%3E3.0.co;2-f)
• Speight, G. et al., 2000. Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. Molecular Psychiatry 5 (3), pp.327-331. (10.1038/sj.mp.4000717)
• Vincent, J. B. et al., 2000. Long repeat tracts at SCA8 in major psychosis. American Journal of Medical Genetics 96 (6), pp.873-876. (10.1002/1096-8628(20001204)96:6<873::AID-AJMG37>3.0.CO;2-9)
• Watts, P. et al. 2000. Linkage analysis in an autosomal dominant 'zonular nuclear pulverulent' congenital cataract, mapped to chromosome 13q11-13. Eye 14 (2), pp.172-175. (10.1038/eye.2000.48)

1999

• Bowen, T. et al. 1999. Linkage studies of bipolar disorder with chromosome 18 markers. American Journal of Medical Genetics 15 (88), pp.503-509. (10.1002/(SICI)1096-8628(19991015)88:5<503::AID-AJMG13>3.0.CO;2-U)
• Bray, N. J. et al. 1999. Embryonic NCAM and schizophrenia: Genetic analysis of regulatory enzymes. Molecular Psychiatry 4 , pp.S32-S32.
• Cardno, A. G. et al., 1999. CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia. Biological Psychiatry 45 (12), pp.1592-1596. (10.1016/s0006-3223(99)00033-5)
• Franks, E. et al., 1999. Eleven trinucleotide repeat loci that map to chromosome 12 excluded from involvement in the pathogenesis of bipolar disorder. American Journal of Medical Genetics 88 (1), pp.67-70. (10.1002/(SICI)1096-8628(19990205)88:1<67::AID-AJMG12>3.0.CO;2-#)
• Guy, C. et al. 1999. CTG18.1 and ERDA-1 CAG/CTG repeat size in bipolar disorder. Neurobiology of Disease 6 (4), pp.302-307. (10.1006/nbdi.1999.0249)
• Guy, C. et al. 1999. No association between a polymorphic CAG repeat in the human potassium channel gene hKCa3 and bipolar disorder. American Journal of Medical Genetics 88 (1), pp.57-60. (10.1002/(sici)1096-8628(19990205)88:1%3C57::aid-ajmg10%3E3.0.co;2-6)
• Jacobsen, N. J. et al., 1999. Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder. Molecular Psychiatry 4 (3), pp.274-279. (10.1038/sj.mp.4000476)
• Jacobsen, N. J. et al., 1999. ATP2A2 mutations in Darier's disease and their relationship to neuropsychiatric phenotypes. Human Molecular Genetics 8 (9), pp.1631-1636. (10.1093/hmg/8.9.1631)
• Kirov, G. et al. 1999. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Molecular Psychiatry 4 (6), pp.558-565.
• Kirov, G. et al. 1999. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. International Journal of Neuropsychopharmacology 2 (4), pp.293-298. (10.1017/s1461145799001601)
• Kirov, G. et al. 1999. Tryptophan hydroxylase gene and manic-depressive illness [letter]. Archives of General Psychiatry 56 (1), pp.98-99. (10.1001/archpsyc.56.1.98)
• Kirov, G. et al. 1999. Bipolar disorder and the serotonin transporter gene: a family-based association study. Psychological Medicine -London- 29 (5), pp.1249-1254. (10.1017/s003329179900882x)
• Sakuntabhai, A. et al., 1999. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nature Genetics 21 (3), pp.271-277.
• Williams, N. M. et al. 1999. Polymorphism screening and association studies of the Wolfram syndrome gene in schizophrenia. Molecular Psychiatry 4 (supp1), pp.S42-S42.

1998

• Asherson, P. et al., 1998. A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Molecular Psychiatry 3 (4), pp.310-320. (10.1038/sj.mp.4000399)
• Bowen, T. et al. 1998. Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophrenia. Molecular Psychiatry 3 (3), pp.266-269. (10.1038/sj.mp.4000400)
• Bowen, T. et al. 1998. Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder. Molecular Psychiatry 3 (1), pp.67-71. (10.1038/sj.mp.4000293)
• Cardno, A. G. et al., 1998. Association between functional psychosis and expanded CAG/CTG repeats is not explained by health stratification [comparative study]. Psychiatric Genetics 8 (1), pp.29-32. (10.1097/00041444-199800810-00005)
• Kirov, G. et al. 1998. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Molecular Psychiatry 3 (4), pp.342-345. (10.1038/sj.mp.4000385)
• Spurlock, G. et al. 1998. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Molecular Psychiatry 3 (1), pp.42-49. (10.1038/sj.mp.4000342)
• Vallada, H. P. et al., 1998. Linkage analysis between bipolar affective disorder and markers on chromosome X. Psychiatric Genetics 8 (3), pp.183-186. (10.1097/00041444-199800830-00008)

1997

• Craddock, N. J. et al. 1997. Expanded CAG/CTG repeats in bipolar disorder: no correlation with phenotypic measures of illness severity. Biological psychiatry 42 (10), pp.876-881. (10.1016/s0006-3223(96)00516-1)
• Guy, C. et al. 1997. Exclusion of expansion of 50 CAG/CTG trinucleotide repeats in bipolar disorder. American Journal of Psychiatry 154 (8), pp.1146-1147.
• Jones, L. et al. 1997. No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia. Molecular Psychiatry 2 (6), pp.478-482. (10.1038/sj.mp.4000297)
• Rees, M. et al., 1997. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Molecular Psychiatry 2 (5), pp.398-402. (10.1038/sj.mp.4000256)
• Speight, G. et al., 1997. Exclusion of CAG/CTG trinucleotide repeat loci which map to chromosome 4 in bipolar disorder and schizophrenia. American Journal of Medical Genetics 74 (2), pp.204-206. (10.1002/(SICI)1096-8628(19970418)74:2<204::AID-AJMG19>3.0.CO;2-M)
• Thomas, N. S. T. et al. 1997. Molecular genetic studies in familial Rett syndrome. European Child & Adolescent Psychiatry 6 (Supp 1), pp.94-94.

1996

• Bowen, T. et al. 1996. Expansion of 50 CAG/CTG repeats excluded in schizophrenia by application of a highly efficient approach using repeat expansion detection and a PCR screening set. American Journal of Human Genetics 59 (4), pp.912-917.
• Craddock, N. J. et al. 1996. Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. British Journal of Psychiatry 169 (1), pp.58-63. (10.1192/bjp.169.1.58)
• Craddock, N. J. et al. 1996. Increasing the efficiency of genomic searches for linkage in complex disorders by DNA pooling of affected sib-pairs. Molecular Psychiatry 1 (1), pp.59-64.
• Craddock, N. J. , O'Donovan, M. C. and Owen, M. J. 1996. Introducing Selfcite 2.0--career enhancing software. BMJ 313 (7072), pp.1659-1660. (10.1136/bmj.313.7072.1659)
• Craddock, N. J. and Owen, M. J. 1996. Modern molecular genetic approaches to psychiatric disease. British Medical Bulletin 52 (3), pp.434-452. (10.1093/oxfordjournals.bmb.a011558)
• Jacobsen, N. et al., 1996. Association study of bipolar disorder at the phospholipase A2 gene (PLA2A) in the Darier's disease (DAR) region of chromosome 12q23-q24.1. Psychiatric Genetics 6 (4), pp.195-199. (10.1097/00041444-199624000-00005)
• Lim, L. C. C. et al., 1996. Assessing the statistical power to detect linkage in a sample of 51 bipolar affective disorder pedigrees. Behavior Genetics 26 (2), pp.113-122. (10.1007/bf02359889)
• O'Donovan, M. C. et al. 1996. Involvement of expanded trinucleotide repeats in common diseases. The Lancet 348 (9043), pp.1739-1740. (10.1016/s0140-6736(05)65870-9)
• O'Donovan, M. C. et al. 1996. Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder. Psychological Medicine -London- 26 (6), pp.1145-1153. (10.1017/s0033291700035868)
• Owen, M. J. and Craddock, N. J. 1996. Modern molecular genetic approaches to complex traits: implications for psychiatric disorders [review]. Molecular Psychiatry 1 (1), pp.21-26.
• Vallada, H. et al., 1996. Linkage studies in bipolar affective disorder with markers on chromosome 21. Journal of affective disorders 41 (3), pp.217-221. (10.1016/s0165-0327(96)00055-9)

1995

• Craddock, N. J. et al. 1995. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. American Journal of Medical Genetics 60 (4), pp.322-324. (10.1002/ajmg.1320600412)
• Craddock, N. J. et al. 1995. Association study of bipolar disorder using a functional polymorphism (Ser311-->Cys) in the dopamine D2 receptor gene. Psychiatric Genetics 5 (2), pp.63-65.
• Dawson, E. et al., 1995. Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1. American Journal of Medical Genetics 60 (2), pp.94-102. (10.1002/ajmg.1320600203)
• Liddell, M. B. , Bayer, A. J. and Owen, M. J. 1995. No evidence that common allelic variation in the Amyloid Precursor Protein (APP) gene confers susceptibility to Alzheimer's disease. Human Molecular Genetics 4 (5), pp.853-858. (10.1093/hmg/4.5.853)
• O'Donovan, M. C. et al. 1995. Expanded CAG repeats in schizophrenia and bipolar disorder [letter]. Nature Genetics 10 (4), pp.380-381. (10.1038/ng0895-380)
• Vallada, H. P. et al., 1995. Linkage studies on chromosome 22 in familial schizophrenia. American Journal of Medical Genetics 60 (2), pp.139-146. (10.1002/ajmg.1320600210)

1994

• Asherson, P. and Owen, M. J. 1994. Anticipation in mental illness. The American Journal of Human Genetics 54 (2), pp.386-387.
• Asherson, P. et al., 1994. Imprinting and anticipation. Are they relevant to genetic studies of schizophrenia?. The British Journal of Psychiatry 164 (5), pp.619-624. (10.1192/bjp.164.5.619)
• Asherson, P. et al., 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia. The Lancet 343 (8904), pp.1045-1045.
• Craddock, N. J. et al. 1994. Bipolar affective puerperal psychosis associated with consanguinity. British Journal of Psychiatry 164 (3), pp.359-364. (10.1192/bjp.164.3.359)
• Craddock, N. J. et al. 1994. Variation at the fragile X locus does not influence susceptibility to bipolar disorder. American Journal of Medical Genetics 54 (2), pp.141-143. (10.1002/ajmg.1320540209)
• Craddock, N. J. , McGuffin, P. and Owen, M. J. 1994. Darier's disease cosegregating with affective disorder [letter]. British Journal of Psychiatry 165 (2), pp.272-272. (10.1192/bjp.165.2.272a)
• Craddock, N. J. and Owen, M. J. 1994. Chromosomal aberrations and bipolar affective disorder [review]. British Journal of Psychiatry 164 (4), pp.507-512. (10.1192/bjp.164.4.507)
• Craddock, N. J. and Owen, M. J. 1994. Is there an inverse relationship between Down's syndrome and bipolar affective disorder? literature review and genetic implications [Review]. Journal of Intellectual Disability Research 38 (6), pp.613-620. (10.1111/j.1365-2788.1994.tb00462.x)
• Craddock, N. J. et al. 1994. Familial cosegregation of major affective disorder and Darier's disease (keratosis follicularis). British Journal of Psychiatry 164 (3), pp.355-358. (10.1192/bjp.164.3.355)
• James, C. M. et al., 1994. Debrisoquine hydroxylase gene polymorphism in motor-neuron disease. Neurodegeneration 3 (2), pp.149-152.
• Korner, J. et al., 1994. Association and haplotype analysis at the tyrosine hydroxylase locus in a combined German-British sample of manic depressive patients and controls. Psychiatric Genetics 4 (3), pp.167-175. (10.1097/00041444-199400430-00007)
• Liddell, M. B. et al. 1994. Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease. Journal of Medical Genetics 31 (3), pp.197-200. (10.1136/jmg.31.3.197)
• Mant, R. et al., 1994. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. American Journal of Medical Genetics 54 (1), pp.21-26. (10.1002/ajmg.1320540106)
• McGuffin, P. et al., 1994. The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia?. British Journal of Psychiatry 164 (5), pp.593-599. (10.1192/bjp.164.5.593)
• Owen, M. J. 1994. The molecular genetics of Alzheimer's disease. Molecular and Cell Biology of Human Diseases Series 1994 (4), pp.92-109.
• Owen, M. J. , Liddell, M. and McGuffin, P. 1994. Alzheimer's disease. British Medical Journal (BMJ) 308 (6930), pp.672-673. (10.1136/bmj.308.6930.672)
• Parfitt, E. et al., 1994. The gene for Darier's disease maps between D12S78 and D12S79. Human Molecular Genetics 3 (1), pp.35-38. (10.1093/hmg/3.1.35)
• Plomin, R. et al., 1994. DNA markers associated with high versus low IQ: The IQ quantitative trait loci (QTL) project. Behavior Genetics 24 (2), pp.107-118. (10.1007/BF01067815)
• Pulver, A. E. et al., 1994. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2. American Journal of Medical Genetics 54 (1), pp.44-50. (10.1002/ajmg.1320540109)
• Shaikh, S. et al., 1994. Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia. American Journal of Medical Genetics 54 (1), pp.8-11. (10.1002/ajmg.1320540104)
• Thapar, A. et al. 1994. The genetics of mental retardation. The British Journal of Psychiatry 164 (6), pp.747. (10.1192/bjp.164.6.747)
• Vallada, H. et al., 1994. Is there a major gene for schizophrenia on chromosome-22. Schizophrenia Research 11 (2), pp.147-147.

1993

• Asherson, P. et al., 1993. Failure to find linkage between schizophrenia and genetic markers on chromosome 21. American Journal of Medical Genetics 48 (3), pp.161-165. (10.1002/ajmg.1320480310)
• Craddock, N. J. et al. 1993. Linkage is excluded between Darier's disease and the Duffy blood group locus in five British families. Annales de Genetique 36 (4), pp.211-213.
• Craddock, N. J. et al. 1993. The gene for Darier's disease maps to chromosome 12q23-q24.1. Human Molecular Genetics 2 (11), pp.1941-1943. (10.1093/hmg/2.11.1941)
• Gill, M. et al., 1993. A linkage study of schizophrenia with DNA markers from the long arm of chromosome 11. Psychological Medicine 23 (1), pp.27-44. (10.1017/S0033291700038824)
• Jones, P. B. et al., 1993. A case-control study of family history and cerebral cortical abnormalities in schizophrenia. Acta Psychiatrica Scandinavica 87 (1), pp.6-12. (10.1111/j.1600-0447.1993.tb03322.x)
• Mant, R. et al., 1993. Susceptibility to schizophrenia and the dopamine d3 receptor gene. American Journal of Human Genetics 53 (3), pp.1654-1654.
• McGuffin, P. and Owen, M. J. 1993. Molecular-genetics and schizophrenia - the current picture. Behavior Genetics 23 (6), pp.558-558.
• Owen, M. J. and McGuffin, P. 1993. Association and linkage: complementary strategies for complex disorders.. Journal of Medical Genetics 30 (8), pp.638-639. (10.1136/jmg.30.8.638)
• Saudino, K. J. et al., 1993. Applying a QTL association approach to temperament. Behavior Genetics 23 (6), pp.564-564.
• Shaikh, S. et al., 1993. The dopamine D3 receptor gene: no association with bipolar affective disorder. Journal of Medical Genetics 30 (4), pp.308-309. (10.1136/jmg.30.4.308)

1992

• Asherson, P. et al., 1992. No evidence for a pseudoautosomal locus for schizophrenia. Linkage analysis of multiply affected families. British Journal of Psychiatry 161 (1), pp.63-68. (10.1192/bjp.161.1.63)
• Craddock, N. J. and Owen, M. J. 1992. Christmas disease and major affective disorder [letter]. British Journal of Psychiatry 160 , pp.715-715. (10.1192/bjp.160.5.715a)
• Dawson, E. et al., 1992. Genetic linkage analysis of schizophrenia using microsatellite repeat polymorphisms on chromosome 12. Schizophrenia Research 6 (2), pp.90-90. (10.1016/0920-9964(92)90086-K)
• Mant, R. et al., 1992. Schizophrenia scepticism. Nature Genetics 2 (1), pp.12-12. (10.1038/ng0992-12)
• Nanko, S. et al., 1992. Linkage Study of Schizophrenia with Markers on Chromosome 11 in Two Japanese Pedigrees. Psychiatry and Clinical Neurosciences 46 (1), pp.155-159. (10.1111/j.1440-1819.1992.tb00828.x)
• O'Donovan, M. C. and Owen, M. J. 1992. Advances and Retreats in the Molecular Genetics of Major Mental Illness. Annals of Medicine 24 (3), pp.171-177. (10.3109/07853899209147816)
• Owen, M. J. and Liddell, M. 1992. Role of amyloid beta-protein in Alzheimer's disease. The Lancet 340 (8823), pp.851-851.
• Owen, M. J. et al. 1992. No association between RFLPs at the porphobilinogen deaminase gene and schizophrenia. Human Genetics 90 (1-2), pp.131-132. (10.1007/BF00210756)
• Owen, M. J. and McGuffin, P. 1992. The molecular genetics of schizophrenia.. British Medical Journal (BMJ) 305 (6855), pp.664-665. (10.1136/bmj.305.6855.664)
• Shaikh, S. , Owen, M. J. and Gill, M. 1992. DRD2 (TGn) repeat polymorphism in a large family data set. Schizophrenia Research 6 (2), pp.91-91. (10.1016/0920-9964(92)90088-M)
• Vallada, H. et al., 1992. Debrisoquine 4-hydroxylase (CYP2D) locus and possible susceptibility to schizophrenia. The Lancet 340 (8812), pp.181-182. (10.1016/0140-6736(92)93266-P)